Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Veeva Systems (VEEV)

NYSE: VEEV · Health Information Services · Pleasanton, CA

Our rating: Positive

Positive reaffirmed at $276.69, moderate conviction, August 28, 2026.

Breaks if: The Positive view breaks if revenue growth decelerates to below 10% in two consecutive quarterly prints over the next 12 months, or if free cash flow margin drops below 35% in any single reported quarter — either outcome strips the justification for a 50× earnings multiple and likely triggers multiple compression on top of estimate cuts. On the other side, sustained re-acceleration above 20% growth paired with stable margins through two consecutive quarters would push the view toward Conviction.

Key figures

Market value$43.1B
Revenue, last 12 months$3.5B
Net income, last 12 months$1.0B
Free cash flow, last 12 monthsn/a
Price to earnings42.5×
Free cash flow yieldn/a
Dividend yield0.0%
Operating margin29.9%
Return on equity14.4%
Beta to the S&P 5000.59
Volatility, annualized38.2%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
July 31, 2026$928M17.6%$1.66n/a
April 30, 2026$883M16.3%$1.57n/a
January 31, 2026$836M16.0%$1.48n/a
October 31, 2025$811M16.0%$1.40n/a
July 31, 2025$789M16.7%$1.19n/a
April 30, 2025$759M16.7%$1.37n/a
January 31, 2025$721M14.3%$1.17n/a
October 31, 2024$699M13.4%$1.13n/a

17 ledger entries and 20 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.